Samsung's Galaxy Watch lineup has long featured sleep apnea detection, but the company has now announced a more advanced, ...

Samsung's advanced sleep apnea detection feature has received clearances from the US FDA and the Korean Ministry of Food and ...

Eli Lilly’s experimental weight-loss drug retatrutide reduced sleep apnea symptoms by over 50% in 68% of trial participants.

It now goes beyond a simple yes or no answer. Samsung first got its Galaxy Watch sleep apnea feature approved at home in ...

Samsung’s upgraded sleep apnea tracking adds breathing disturbance frequency levels, but Wear OS requirements mean some older Galaxy Watches will remain limited to basic alerts when the feature ...

Eli Lilly's investigational weight loss drug retatrutide reversed sleep apnea in around 15% of participants with type 2 ...

Sleep apnea is diagnosed with sleep tests that measure number of breaths during sleep, interruptions in sleep, oxygen levels, and sleep movements.

In two phase 3 trials, retatrutide significantly reduced sleep apnea severity and produced substantial weight loss in adults with overweight and obesity, with or without comorbid type 2 diabetes.

Interstitial lung disease and obstructive sleep apnea share a bidirectional pathophysiology that may complicate screening and ...

Incretin-based therapies, particularly tirzepatide and liraglutide, can reduce obstructive sleep apnea severity in adults ...

Struggling with snoring or disrupted sleep? The FDA-cleared Hushd Avera mouthguard is designed to help improve airflow while ...

Samsung is upgrading the sleep apnea check on the Galaxy Ring and several Galaxy Watches. The company announced the change in ...